Toda, Japan

Akira Tsunashima

This inventor holds 1 USPTO granted patent. Top assignee: Tanabe Seiyaku Company, Limited. Active years: 1986.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Akira Tsunashima. Retrieved from https://idiyas.com/inventor/akira-tsunashima

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1986

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Akira Tsunashima: Innovator in Bronchodilating Compounds

Introduction

Akira Tsunashima is a notable inventor based in Toda, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of bronchodilating agents. His innovative work has led to the creation of a novel carbostyril derivative that showcases potent bronchodilating activity.

Latest Patents

Tsunashima holds a patent for a bronchodilating compound, described as a novel carbostyril derivative of the formula: ##STR1## or a pharmaceutically acceptable acid addition salt thereof. This compound demonstrates effective bronchodilating properties, making it a valuable asset in respiratory therapies.

Career Highlights

Throughout his career, Akira Tsunashima has been associated with Tanabe Seiyaku Company, Limited, where he has focused on pharmaceutical innovations. His work has contributed to advancements in treatments for respiratory conditions, enhancing the quality of life for many patients.

Collaborations

Tsunashima has collaborated with esteemed colleagues, including Takeo Iwakuma and Katsuo Ikezawa, who have supported his research endeavors. Their combined expertise has fostered a productive environment for innovation in the pharmaceutical sector.

Conclusion

Akira Tsunashima's contributions to bronchodilating compounds exemplify the impact of dedicated inventors in the field of medicine. His work continues to influence respiratory therapies and showcases the importance of innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…